Prioritizing Collaboration in Research
Explore the priorities of Room 204 experts focusing on knowledge sharing, clinical trials, and redefining medical definitions. Emphasizing interaction between lab and clinic, enhancing clinical trials, and reassessing current definitions for better clinical applications.
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
You are allowed to download the files provided on this website for personal or commercial use, subject to the condition that they are used lawfully. All files are the property of their respective owners.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.
E N D
Presentation Transcript
Group 2: Room 204 Jennifer Gudeman, PharmD; Cynthia Gyamfi-Bannerman, MD, MS; Narmada Lavu, MD; Thomas McElrath, MD, PhD; Sam Mesiano, PhD; Morgan Peltier, PhD; George Saade, MD; Brandy Taylor, PhD
Priorities: Sharing of Knowledge Encourage sharing of knowledge and experience among trainees Fellows, faculty should spend time in the lab (already happening) Post docs should spend time in the clinic Immersion in clinic, more than one day, week v. months Understanding the phenotype, what are the conditions, how are they treated Answering clinically important questions Even time in the OR to learn anatomy Encourage dialogue between the 2 sides
Priorities: Clinical Trials Encouraging more clinical trials Pilot studies Encouraging basic science researchers to plan the path from experiment to clinical studies Understand the trajectory to clinical application
Priorities: Reconsidering Definitions Definitions Figure out where they came from Preterm is arbitrary Preclampsia is not agreed upon by clinicians Initially defined as a screen for eclampsia Cannot agree on phenotypes What is clinically applicable and how can we get that information from basic science? When do we deliver? Risk/benefits What is the ultimate goal, stopping labor or knowing which fetus will benefit from delivery
